Cytek Biosciences, Inc.
CTKB
$4.81
$0.153.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -0.01% | -1.28% | -5.88% | -5.78% | -5.48% |
| Total Receivables | -9.48% | 2.30% | 19.05% | 17.12% | 26.63% |
| Inventory | 6.35% | 10.38% | 10.56% | 10.78% | -0.36% |
| Prepaid Expenses | -19.29% | -12.09% | 4.79% | -9.38% | 43.84% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -18.67% | -34.05% | -62.36% | 5.80% | 10.47% |
| Total Current Assets | -1.28% | -0.32% | -1.12% | -0.44% | -0.33% |
|
|
|||||
| Total Current Assets | -1.28% | -0.32% | -1.12% | -0.44% | -0.33% |
| Net Property, Plant & Equipment | -8.57% | 12.31% | 4.24% | 2.00% | 26.59% |
| Long-term Investments | -0.10% | 0.07% | 0.20% | 3.18% | 3.24% |
| Goodwill | -0.10% | 0.07% | 0.20% | 3.18% | 3.24% |
| Total Other Intangibles | -20.08% | -19.18% | -16.43% | -13.74% | -13.16% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -85.37% | -87.17% | -86.62% | 20.87% | 12.29% |
| Total Assets | -9.40% | -6.94% | -7.60% | 0.75% | 1.98% |
|
|
|||||
| Total Accounts Payable | 22.69% | 7.91% | 15.93% | 41.62% | 114.76% |
| Total Accrued Expenses | 14.93% | 9.30% | 16.07% | 7.76% | 53.86% |
| Short-term Debt | 530.64% | 321.29% | 36.99% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -47.52% | -30.93% | -58.64% | 82.36% | 70.09% |
| Total Finance Division Other Current Liabilities | 6.42% | 14.02% | 15.65% | 10.88% | 16.56% |
| Total Other Current Liabilities | 6.42% | 14.02% | 15.65% | 10.88% | 16.56% |
| Total Current Liabilities | 15.10% | 19.57% | 14.99% | 19.76% | 39.88% |
|
|
|||||
| Total Current Liabilities | 15.10% | 19.57% | 14.99% | 19.76% | 39.88% |
| Long-Term Debt | -68.90% | -57.95% | -50.00% | -47.01% | -40.53% |
| Short-term Debt | 530.64% | 321.29% | 36.99% | -- | -- |
| Capital Leases | -4.26% | 80.46% | 85.94% | 73.98% | 74.03% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -2.54% | -0.78% | -0.24% | -20.55% | -15.85% |
| Total Liabilities | 7.96% | 17.96% | 15.46% | 10.01% | 22.37% |
|
|
|||||
| Common Stock & APIC | 5.16% | 4.46% | 2.39% | 1.21% | -1.22% |
| Retained Earnings | -154.41% | -158.80% | -189.04% | -28.60% | -13.99% |
| Treasury Stock & Other | 7,307.89% | 489.00% | 13,906.25% | 712.87% | 80.51% |
| Total Common Equity | -14.73% | -13.69% | -13.64% | -1.79% | -2.97% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.73% | -13.69% | -13.64% | -1.79% | -2.97% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.73% | -13.69% | -13.64% | -1.79% | -2.97% |
|
|
|||||